In the future, ConnDx could be deployed for bacterial infections if these can be diagnosed by RDTs (e.g. for C Reactive Protein), leading to better-informed antibiotic prescriptions, which is important in fighting antimicrobial resistance [45]. The gene discussed is CRP; the disease is bacterial infectious disease.